Barriers to Healthcare Access and Long-Term Survival After an Acute Coronary Syndrome.

Journal of General Internal Medicine
Nathaniel A ErskineRobert J Goldberg

Abstract

Barriers to healthcare are common in the USA and may result in worse outcomes among hospital survivors of an acute coronary syndrome (ACS). To examine the relationship between barriers to healthcare and 2-year mortality after hospital discharge for an ACS. Longitudinal study. Survivors of an ACS hospitalization were recruited from 6 medical centers in central Massachusetts and Georgia in 2011-2013. Study participants with a confirmed ACS reported whether they had a financial-related healthcare barrier, no usual source of care, or a transportation-related healthcare barrier around the time of hospital admission. None. Cox regression analyses calculated adjusted hazard ratios (aHRs) for 2-year all-cause mortality for the three healthcare barriers while controlling for several demographic, clinical, and psychosocial characteristics. The mean age of study participants (n = 2008) was 62 years, 33% were women, and 77% were non-Hispanic white. One third of patients reported a financial barrier, 17% lacked a usual source of care, and 12% had a transportation barrier. Five percent (n = 100) died within 2 years after hospital discharge. Compared to patients without these barriers, those lacking a usual source of care and with barriers to...Continue Reading

References

Sep 15, 2001·Journal of General Internal Medicine·K KroenkeJ B Williams
May 24, 2006·Archives of Internal Medicine·Robert L SpitzerBernd Löwe
Mar 16, 2007·JAMA : the Journal of the American Medical Association·Ali R RahimiHarlan M Krumholz
May 29, 2008·Journal of General Internal Medicine·Lynn A BlewettPeter B Scal
Jan 31, 2009·Cadernos de saúde pública·Maria Laura Vidal CarretMarlos Rodrigues Domingues
Jul 8, 2010·JAMA : the Journal of the American Medical Association·Benjamin J PowersHayden B Bosworth
Dec 28, 2010·The American Journal of Cardiology·Michael A GagliaRon Waksman
Jan 13, 2011·Statistics in Medicine·Ian R WhiteAngela M Wood
Feb 15, 2011·BMC Health Services Research·Zhenxiang Zhao, Melissa Winget
Jul 24, 2012·Journal of General Internal Medicine·Derek K NgJ Hunter Young
Sep 20, 2012·Circulation. Cardiovascular Quality and Outcomes·Molly E WaringUNKNOWN TRACE-CORE Investigators
Dec 19, 2012·Circulation·Patrick T O'GaraUNKNOWN American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Apr 2, 2013·Journal of Community Health·Samina T SyedLisa K Sharp
Feb 21, 2014·Journal of General Internal Medicine·Erica S SpatzJoseph S Ross
Feb 26, 2014·Circulation·Judith H LichtmanUNKNOWN American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascu
Dec 1, 2014·The American Journal of Emergency Medicine·Alexander T JankePhillip D Levy
May 7, 2015·The New England Journal of Medicine·David BlumenthalRachel Nuzum
May 27, 2015·The American Journal of Medicine·Robert J GoldbergUNKNOWN TRACE-CORE investigators
Sep 7, 2016·JAMA : the Journal of the American Medical Association·Brian W PowersSachin H Jain
Oct 16, 2016·Journal of the American Heart Association·Adam L BeckmanErica S Spatz
Feb 16, 2017·BMC Cardiovascular Disorders·Kirnvir K DhaliwalDavid J T Campbell

❮ Previous
Next ❯

Citations

Jul 19, 2019·The Western Journal of Emergency Medicine·Amar TomarJohn R Richards
Oct 31, 2018·Journal of the American Heart Association·Andrew E Levy, Larry A Allen
Feb 25, 2021·The American Journal of Nursing·Amie M Koch
Jul 18, 2021·The American Journal of Medicine·Eric Y DingRobert J Goldberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.